Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aminaftone
2. Aminaphthone
3. Capilarema
4. Capillarema
1. Aminaftone
2. Aminaphthone
3. 14748-94-8
4. Aminaphtone
5. (1,4-dihydroxy-3-methylnaphthalen-2-yl) 4-aminobenzoate
6. 03jlx11pe9
7. Capilarema
8. Unii-03jlx11pe9
9. Capillarema
10. Menatriol
11. Capillarema (tn)
12. Einecs 238-809-8
13. Aminonaphthone
14. Aminaphthone [mart.]
15. Aminaphtone [who-dd]
16. Schembl12157532
17. Dtxsid00163725
18. Chebi:135317
19. Zinc5419379
20. Cs-6667
21. Db13039
22. Hy-19890
23. D07566
24. 3-methyl-1,2,4-naphthalenetriol-2-(4-aminobenzoate)
25. Q17620495
26. 1,2,4-naphthalenetriol, 3-methyl-, 2-(4-aminobenzoate)
27. 1,2,4-naphthalenetriol, 3-methyl-, 2-(p-aminobenzoate)
Molecular Weight | 309.3 g/mol |
---|---|
Molecular Formula | C18H15NO4 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 309.10010796 g/mol |
Monoisotopic Mass | 309.10010796 g/mol |
Topological Polar Surface Area | 92.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 421 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
Global Sales Information
ABOUT THIS PAGE
54
PharmaCompass offers a list of Aminaftone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aminaftone manufacturer or Aminaftone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aminaftone manufacturer or Aminaftone supplier.
PharmaCompass also assists you with knowing the Aminaftone API Price utilized in the formulation of products. Aminaftone API Price is not always fixed or binding as the Aminaftone Price is obtained through a variety of data sources. The Aminaftone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 03JLX11PE9 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 03JLX11PE9, including repackagers and relabelers. The FDA regulates 03JLX11PE9 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 03JLX11PE9 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 03JLX11PE9 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 03JLX11PE9 supplier is an individual or a company that provides 03JLX11PE9 active pharmaceutical ingredient (API) or 03JLX11PE9 finished formulations upon request. The 03JLX11PE9 suppliers may include 03JLX11PE9 API manufacturers, exporters, distributors and traders.
click here to find a list of 03JLX11PE9 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
03JLX11PE9 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 03JLX11PE9 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 03JLX11PE9 GMP manufacturer or 03JLX11PE9 GMP API supplier for your needs.
A 03JLX11PE9 CoA (Certificate of Analysis) is a formal document that attests to 03JLX11PE9's compliance with 03JLX11PE9 specifications and serves as a tool for batch-level quality control.
03JLX11PE9 CoA mostly includes findings from lab analyses of a specific batch. For each 03JLX11PE9 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
03JLX11PE9 may be tested according to a variety of international standards, such as European Pharmacopoeia (03JLX11PE9 EP), 03JLX11PE9 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (03JLX11PE9 USP).